Skip to content

Hyperthermia associated with 3,4‐methylenedioxyethamphetamine (‘Eve’)

B Tehan, R D Hardern, A. Bodenham

Anaesthesia June 1, 1993 DOI: 10.1111/j.1365-2044.1993.tb07072.x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population A patient admitted with hyperthermia and related symptoms
Keywords Malignant hyperthermia Anesthesia
Citations 48
Key findings The patient's symptoms were associated with MDEA (Eve) rather than MDMA, and malignant hyperthermia was ruled out by in vitro testing.

Abstract

Summary A patient was admitted with hyperthermia, muscle rigidity, rhabdomyolysis and disseminated intravascular coagulation. He was initially thought to have taken 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), but subsequent toxicology revealed the presence of 3,4‐methylenedioxyethamphetamine (MDEA, ‘Eve’), its sister drug, in his blood. Subsequent in vitro testing for malignant hyperthermia proved to be negative.

Citations in the library

Explore topics